148 related articles for article (PubMed ID: 7586764)
1. Treatment of acute myocardial infarction with streptokinase does not appear to modulate circulating neutrophil function.
Adams SA; Froese SP; Green BK; Commerford PJ; Kirsch RE; Shephard EG; Robson SC
Clin Cardiol; 1995 Aug; 18(8):459-63. PubMed ID: 7586764
[TBL] [Abstract][Full Text] [Related]
2. Thrombolytic treatment in acute myocardial infarction: neutrophil activation, peripheral leucocyte responses, and myocardial injury.
Ranjadayalan K; Umachandran V; Davies SW; Syndercombe-Court D; Gutteridge CN; Timmis AD
Br Heart J; 1991 Jul; 66(1):10-4. PubMed ID: 1854566
[TBL] [Abstract][Full Text] [Related]
3. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.
Salvioni A; Perego GB; Marenzi G; Lauri G; Giraldi F; Grazi S; Guazzi MD
Eur Heart J; 1996 Feb; 17(2):230-6. PubMed ID: 8732376
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil adherence-augmenting and chemotactic plasma activities in acute myocardial infarction: effect of fibrinolytic treatment.
Klimas R; Siminiak T; Wysocki H
Int J Cardiol; 1993 Dec; 42(3):239-44. PubMed ID: 8138332
[TBL] [Abstract][Full Text] [Related]
5. Plasma-mediated neutrophil activation during acute myocardial infarction: role of platelet-activating factor.
Siminiak T; Egdell RM; O'Gorman DJ; Dye JF; Sheridan DJ
Clin Sci (Lond); 1995 Aug; 89(2):171-6. PubMed ID: 7554758
[TBL] [Abstract][Full Text] [Related]
6. Thrombolytic versus fibrinogenolytic activity of rt-PA and streptokinase in patients with acute myocardial infarction.
Prisco D; Bonechi F; Scarti L; Tramontana M; Abbate R; Gensini GF
Angiology; 1990 Aug; 41(8):616-20. PubMed ID: 2117862
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the fibrinolytic system components during acute myocardial infarction.
Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
[TBL] [Abstract][Full Text] [Related]
8. Preserved oxidative activity and chemotaxis of circulating neutrophils in patients with acute myocardial infarction.
Obel N; Andersen PL; Andersen HR
Eur Heart J; 1993 Jun; 14(6):790-4. PubMed ID: 8391984
[TBL] [Abstract][Full Text] [Related]
9. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
10. Acylated streptokinase--plasminogen complex in patients with acute myocardial infarction.
Walker ID; Davidson JF; Rae AP; Hutton I; Lawrie TD
Thromb Haemost; 1984 Apr; 51(2):204-6. PubMed ID: 6377564
[TBL] [Abstract][Full Text] [Related]
11. Relationship between initial white blood cell counts, stage of acute myocardial infarction evolution at presentation, and incidence of Thrombolysis In Myocardial Infarction-3 flow after streptokinase.
Wong CK; French JK; Gao W; White HD
Am Heart J; 2003 Jan; 145(1):95-102. PubMed ID: 12514660
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic therapy with streptokinase stimulates collagen breakdown.
Peuhkurinen KJ; Risteli L; Melkko JT; Linnaluoto M; Jounela A; Risteli J
Circulation; 1991 Jun; 83(6):1969-75. PubMed ID: 2040049
[TBL] [Abstract][Full Text] [Related]
13. Influence of heparin on fibrinogen and D-dimer plasma levels in acute myocardial infarction treated with streptokinase.
Salvioni A; Marenzi GC; Agostoni P; Grazi S; Guazzi MD
Eur Heart J; 1994 May; 15(5):654-9. PubMed ID: 8056006
[TBL] [Abstract][Full Text] [Related]
14. Effect of pretreatment antistreptokinase antibody and streptococcal infection on the efficacy and dosage of streptokinase in acute myocardial infarction.
Abuosa AM; Akhras F; Sorour K; El-Said G; El-Tobgy S; Kinsara AJ
Saudi Med J; 2005 Jun; 26(6):934-6. PubMed ID: 15983677
[TBL] [Abstract][Full Text] [Related]
15. [The effect of acetylsalicylic acid and streptokinase on the restoration of systolic heart function in patients after a myocardial infarct].
Chubuchna II
Lik Sprava; 1997; (6):48-52. PubMed ID: 9589926
[TBL] [Abstract][Full Text] [Related]
16. Procoagulant effects of thrombolytic therapy in acute myocardial infarction.
Wang Y; Liu Q; Zhu J; Yuan Z; Ma X
Chin Med Sci J; 2002 Mar; 17(1):36-9. PubMed ID: 12894883
[TBL] [Abstract][Full Text] [Related]
17. The incidence and mechanism of hypotension following thrombolytic therapy for acute myocardial infarction with streptokinase-containing agents--lack of relationship to pretreatment streptokinase resistance.
Gemmill JD; Hogg KJ; Douglas JT; Dunn FG; Lowe GD; Rae AP; Hillis WS
Eur Heart J; 1993 Jun; 14(6):819-25. PubMed ID: 8325311
[TBL] [Abstract][Full Text] [Related]
18. A pilot study of streptokinase-induced endothelial injury and platelet activation following acute myocardial infarction.
Lip GY; Lydakis C; Nuttall SL; Landray MJ; Watson RD; Blann AD
J Intern Med; 2000 Oct; 248(4):316-8. PubMed ID: 11086642
[TBL] [Abstract][Full Text] [Related]
19. Correlation between D-dimer levels and coronary artery reperfusion in acute myocardial infarction patients after thrombolytic treatment.
Cakar MA; Gunduz H; Varim C; Ozdemir F; Vatan MB; Akdemir R
Blood Coagul Fibrinolysis; 2013 Sep; 24(6):608-12. PubMed ID: 23917585
[TBL] [Abstract][Full Text] [Related]
20. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
